0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

Arch Dermatol. 2012;148(3):290. doi:10.1001/archdermatol.2011.519.
Text Size: A A A
Published online

PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN IMMUNOBULLOUS DISEASES WITH ALENDRONATE

The mainstay of therapy of immunobullous disease continues to be long-term glucocorticoid use, despite the risks of bone loss and fracture. Bisphosphonate use has been advocated in treatment guidelines for patients being treated with glucocorticoids for longer than 3 months. However, published trials have involved white patients with rheumatologic and respiratory diseases for which the doses are generally lower than for immunobullous diseases. In this randomized, double-blind, placebo-controlled trial, Tee et al demonstrate a significant increase in bone mineral density with alendronate therapy in patients treated with oral corticosteroids for immunobullous disease, suggesting that using bisphosphonates is imperative in this patient population.

See Article

IMPACT OF SMOKING IN CUTANEOUS LUPUS ERYTHEMATOSUS

Between 59% and 85% of patients with systemic lupus erythematosus (LE) develop dermatologic involvement. The specific manifestations of cutaneous LE are diverse and can be grouped into acute, subacute, and chronic subtypes. In this prospective longitudinal cohort study, Piette et al demonstrate that current smokers with lupus have worse disease and lower quality of life and respond less well to treatment when they need both antimalarial agents and immunomodulators. These data further strengthen the need for smoking cessation in the cutaneous LE population.

See Article

ASSOCIATION OF PHARYNGITIS WITH ORAL ANTIBIOTIC USE FOR THE TREATMENT OF ACNE

Many inconsistent concerns have been voiced about the safety of long-term antibiotic use. Because of the high prevalence of acne and frequent use of antibiotics to control acne, patients with acne are the ideal group in which to study the effects of long-term antibiotic use. In this cross-sectional prospective cohort study, Margolis et al demonstrate that the odds of developing self-reported pharyngitis was more than 3 times that at baseline in patients receiving oral antibiotics for acne vs those who were not receiving oral antibiotics. The cause of this phenomenon is not known, but this finding was not associated with group A streptococcus.

See Article

POPULATION-BASED ESTIMATES OF THE OCCURRENCE OF MULTIPLE VS FIRST PRIMARY BASAL CELL CARCINOMAS IN 4 EUROPEAN REGIONS

Basal cell carcinoma (BCC) is the most common cancer among whites by far, and incidence rates are increasing worldwide. Multiple primary tumors in patients with a BCC history and the large total number of patients with BCC translate into substantial costs and an important public health burden. However, the precise magnitude of BCC incidence and prevalence remains unknown because the total number of BCC cases continues to be markedly underreported by cancer registries that often report information only for first primary BCC. In this cancer registry evaluation, de Vries et al demonstrate that the total annual incidence rates are about 1.3 times higher than the rates of first primary BCC.

See Article

SOLUBLE ADENYLYL CYCLASE ANTIBODY PROFILE AS A DIAGNOSTIC ADJUNCT IN THE ASSESSMENT OF PIGMENTED LESIONS

Melanocytic proliferations remain among the most critical diagnostic challenges in the field of dermatopathology. A few immunohistochemical stains, such as HMB45 and Ki67, are routinely used to distinguish benign lesions from melanoma. Neither is specific or especially sensitive. In this qualitative study, Magro et al demonstrate that a novel monoclonal antibody against soluble adenylyl cyclase (sAC) produced distinctive patterns that paralleled melanoma genesis. The sAC expression pattern is complex but seems discriminatory, and it seems to provide a confirmatory test to distinguish benign from malignant lesions.

See Article

First Page Preview

View Large
First page PDF preview

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

293 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs